Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000947871-24-000868
Filing Date
2024-11-08
Accepted
2024-11-08 19:15:49
Documents
2
Group Members
ORBIMED CAPITAL GP IX LLCORBIMED CAPITAL GP VII LLCORBIMED CAPITAL GP VIII LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ss4093989_sc13d.htm SC 13D 135010
2 JOINT FILING AGREEMENT ss4093989_ex9901.htm EX-99.1 7852
  Complete submission text file 0000947871-24-000868.txt   144731
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

EIN.: 133976876 | State of Incorp.: DE
Type: SC 13D

Mailing Address C/O LOMOND THERAPEUTICS HOLDINGS, INC. 8 THE GREEN STE 8490 DOVER DE 19901
Business Address C/O LOMOND THERAPEUTICS HOLDINGS, INC. 8 THE GREEN STE 8490 DOVER DE 19901 561 464 2841
Lomond Therapeutics Holdings, Inc. (Subject) CIK: 0001900520 (see all company filings)

EIN.: 872959575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-93945 | Film No.: 241442498
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)